Company Pharmacolog i Uppsala AB
Equities
PERP B
SE0019071812
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0832 SEK | -9.37% | -14.23% | +47.00% |
04-24 | Perpetua Medical AB Appoints Camilla Lonn as CFO | CI |
04-23 | Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B | CI |
Business Summary
Number of employees: 10
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drugs Quality Assurance Solutions
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.76% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hans Erik Dahlin
FOU | Founder | 79 | 14/01/07 |
LiseLotte Söder
DFI | Director of Finance/CFO | 60 | 31/12/20 |
Chairman | 76 | 31/12/16 | |
Asal Attabipour
PRN | Corporate Officer/Principal | 41 | 31/12/21 |
Susanne Grimsby
LAW | General Counsel | 63 | 31/12/17 |
Torbjörn Norberg
PRN | Corporate Officer/Principal | 59 | 31/12/17 |
Åsa Stroofe
SAM | Sales & Marketing | 56 | 31/05/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 31/12/16 | |
Hans Erik Dahlin
FOU | Founder | 79 | 14/01/07 |
Ragnar Linder
BRD | Director/Board Member | 71 | 31/12/18 |
Director/Board Member | 47 | 29/06/23 | |
Anders Hedlund
CEO | Chief Executive Officer | - | 29/06/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,250,342 | 32,532,202 ( 49.10 %) | 0 | 49.10 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+47.00% | 894K | |
-15.52% | 18.54B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+25.21% | 1.23B | |
-13.90% | 989M | |
-21.76% | 896M | |
-5.01% | 744M | |
-19.85% | 673M | |
+7.31% | 490M |
- Stock Market
- Equities
- PERP B Stock
- Company Pharmacolog i Uppsala AB